Medicare Enrolled
Dr. Ravindra Edupuganti, M.D.
Nuclear Cardiology Physician · Marietta, GA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Edupuganti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Edupuganti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Edupuganti
Dr. Ravindra Edupuganti is a nuclear cardiology physician in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Edupuganti performed 2,255 Medicare services across 1,757 unique beneficiaries.
Between the years covered by Open Payments, Dr. Edupuganti received a total of $6,225 from 30 pharmaceutical and/or device companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Edupuganti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 40% volume in GA
$6,225 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,255
Medicare services
Top 40% in GA for nuclear cardiology physician
1,757
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
639 | $6 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
413 | $88 | $282 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
260 | $64 | $178 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
230 | $10 | $58 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
215 | $50 | $232 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
90 | $11 | $46 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
82 | $15 | $58 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
71 | $56 | $259 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
47 | $4 | $20 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $100 | $341 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $96 | $255 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $119 | $382 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
24 | $20 | $94 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
24 | $19 | $52 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
22 | $2 | $19 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
16 | $6 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $63 | $190 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
11 | $55 | $244 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.2% high complexity
12.8% medium
76.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,225
Total received (2018-2024)
Avg $889/year across 7 years
Top 36% in GA for nuclear cardiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
315
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,225 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,110
2023
$934
2022
$1,325
2021
$486
2020
$490
2019
$1,093
2018
$788
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$253
AstraZeneca Pharmaceuticals LP
$173
Janssen Pharmaceuticals, Inc
$160
Novo Nordisk Inc
$120
Amgen Inc.
$89
Merck Sharp & Dohme LLC
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
PFIZER INC.
$41
Abbott Laboratories
$25
CVRx, Inc.
$23
Esperion Therapeutics, Inc.
$23
Alnylam Pharmaceuticals Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
SANOFI-AVENTIS U.S. LLC
$18
Kiniksa Pharmaceuticals International, plc
$15
Top 3 companies account for 52.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,022
Amgen Inc.
$843
AstraZeneca Pharmaceuticals LP
$662
PFIZER INC.
$418
Janssen Pharmaceuticals, Inc
$341
HeartFlow, Inc.
$339
Merck Sharp & Dohme LLC
$323
SANOFI-AVENTIS U.S. LLC
$292
Boehringer Ingelheim Pharmaceuticals, Inc.
$265
Amarin Pharma Inc.
$264
Abbott Laboratories
$226
Boston Scientific Corporation
$211
E.R. Squibb & Sons, L.L.C.
$210
Novo Nordisk Inc
$157
Medtronic Vascular, Inc.
$133
Merck Sharp & Dohme Corporation
$105
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$80
Esperion Therapeutics, Inc.
$52
Edwards Lifesciences Corporation
$39
CVRx, Inc.
$39
Regeneron Healthcare Solutions, Inc.
$34
Gilead Sciences, Inc.
$28
Alnylam Pharmaceuticals Inc.
$22
Actelion Pharmaceuticals US, Inc.
$21
Lantheus Medical Imaging, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$16
ARBOR PHARMACEUTICALS, INC.
$16
Kiniksa Pharmaceuticals International, plc
$15
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · Arcalyst · BRILINTA · Barostim Neo System · CARDIOMEMS · CHANTIX · Corlanor · Definity · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FFRct · HeartWare HVAD · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LifeVest · Livalo · MULTAQ · Mitra Clip system · NEXLETOL · ONGLYZA · OPSUMIT · Ozempic · PRADAXA · PRALUENT · RESONATE · Repatha · Rybelsus · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nuclear cardiology physicians within 10 mi
6
Per 100K population
0.8
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Edupuganti is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Edupuganti experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Edupuganti performed 639 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Edupuganti receive payments from pharmaceutical companies?
Yes. Dr. Edupuganti received a total of $6,225 from 30 companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Edupuganti's costs compare to other nuclear cardiology physicians in Marietta?
Dr. Edupuganti's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Edupuganti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Cardiology Physicians in Marietta
Browse nuclear cardiology physicians in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Cardiology Physicians in GA
Nuclear cardiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Cardiology Physicians in GA
Which GA nuclear cardiology physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology